Skip to content
Screener

Cencora COR Q1 2026 earnings

Reported February 4, 2026 · Before market open

Revenue$85.9BMiss by $126.9M
EPS$4.08Beat by $0.03
Revenue estimate$86.1B
EPS estimate$4.05

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$88.1B
EPS estimate$4.51

Financials

Q1 2026

Income statement

See full
Revenue$85.9B+5.5%
Gross profit$3.1B+20.1%
Operating income$760.4M+7.7%
Net income$559.6M+14.5%
EPS (diluted)$2.87+14.8%

Balance sheet

See full
Cash & equivalents$1.8B-45.6%
Total debt$7.6B+27.7%
Total equity$1.9B+742%
Total assets$78.4B+13.5%

Cash flow

See full
Operating cash flow-$2.3B+15.2%
CapEx$119.4M+12.7%
Free cash flow-$2.4B+14.2%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$65.52B+50.9%
Enterprise value$71.35B+54.6%
P/S0.2×+0.1×

Profitability

See full
Gross margin3.7%+0.4pp
Operating margin0.8%+0.1pp
FCF margin1.1%+1.0pp

Returns & leverage

See full
Debt / equity4×-22.2×
Current ratio0.9×0.0×

Segments

By product

See full
Alliance Healthcare$6.5B+8.9%
Animal Health$1.5B+6.6%
Other Healthcare Solutions$1.1B+13.9%
Other non-strategic businesses$657.6M+5.6%

By segment

See full
U.S. Healthcare Solutions$76.2B+5.0%
International Healthcare Solutions$7.6B+9.6%

FAQ

When did Cencora report Q1 2026 earnings?
Cencora (COR) reported Q1 2026 earnings on February 4, 2026 before market open.
What were Cencora's Q1 2026 revenue and EPS?
Cencora reported revenue of $85.9B and eps of $4.08 for Q1 2026.
Did Cencora beat estimates in Q1 2026?
Revenue missed the consensus estimate of $86.1B by $126.9M. EPS beat the consensus estimate of $4.05 by $0.03.
How did Cencora's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 5.5% from $81.5B a year earlier and eps grew 9.4% from $3.73.
Where can I find Cencora's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001140859-26-000004) and the 10-Q periodic report (0001140859-26-000006) directly on SEC EDGAR. The filing index links above go to sec.gov.